[1]陳惠紅,劉東亮,潘月.病毒性心肌炎患兒心率變異性與心率減速力的相關(guān)性分析[J].實(shí)用心電學(xué)雜志,2020,29(1):16-18.
[2]蔡繼銳,王浩然,田躍軍,劉東亮,梁超.膝骨關(guān)節(jié)炎合并高血壓患者血清COMP水平及其與左室肥厚的相關(guān)性[J].廣東醫(yī)學(xué),2020,41(17):1763-1767.
[3]蔡繼銳,林偉,楊光,邢浩,劉東亮,田躍軍,黃圣明.寧心寶膠囊聯(lián)合鹽酸胺碘酮片治療陣發(fā)性心房顫動(dòng)患者的療效觀察[J].現(xiàn)代診斷與治療,2020,31(16):2557-2559.
[4]張文瓊,劉東亮,胡新榮,蔡繼銳.ACS抗血小板治療進(jìn)展[J].空軍醫(yī)學(xué)雜志,2018,34(5):351-354.
[5]王東升,劉東亮.中西醫(yī)結(jié)合治療冠心病心絞痛的臨床療效觀察[J].保健醫(yī)學(xué)研究與實(shí)踐,2017,14(3):67-68,105.
[6]陸振濤,劉東亮,崔四龍.依那普利聯(lián)合倍他樂(lè)克治療擴(kuò)張型心肌病心功能不全對(duì)照研究[J].臨床心身疾病雜志,2017,23(5):56-57,67.
[7]王前勝,王艷偉,劉東亮,胡新榮,蔡繼銳.強(qiáng)化他汀治療對(duì)合并睡眠呼吸暫停綜合征的冠心病患者PCI術(shù)后的影響[J].實(shí)用藥物與臨床,2017,20(7):763-766.
[8]劉東亮,王前勝,蔡繼銳,呂云霞,彭庚,胡新榮,董艷彩,崔四龍,林偉.經(jīng)導(dǎo)管主動(dòng)脈瓣植入術(shù)后并發(fā)三度房室傳導(dǎo)阻滯一例[J].中華心血管病雜志,2015,43(12):1099.
[9]金焱,楊光,王前勝,劉東亮.蓮花清瘟膠囊治療急性病毒性心肌炎的療效及對(duì)血清cTnT、CK－MB、CRP的影響[J].中國(guó)老年學(xué)雜志,2015,(12):3285-3286.
[10]蔡繼銳,毛艷,劉東亮,呂云霞,董艷彩.有氧康復(fù)運(yùn)動(dòng)治療慢性心力衰竭的療效觀察[J].中國(guó)心血管病研究,2013,11(11):873-875.
[11]劉東亮,彭庚.Churg-Strauss綜合征伴冠狀動(dòng)脈病變一例[J].中華心血管病雜志,2013,41(7):616-617.
[12]潘月,潘登,潘二明,李中健,劉東亮,梁興國(guó).急性右室心肌梗死的心電向量圖觀察[J].實(shí)用心電學(xué)雜志,2015,(2):138-148.
[13]王前勝,劉東亮,呂云霞,董艷彩.冠心舒通膠囊對(duì)冠狀動(dòng)脈支架置入術(shù)后支架內(nèi)再狹窄的影響[J].中國(guó)心血管病研究,2014,12(8):757-761.
[14]蔡繼銳,劉東亮,楊春香,呂云霞,董艷彩,林偉,陸振濤,金焱,彭庚.國(guó)產(chǎn)瑞替普酶和進(jìn)口阿替普酶對(duì)ST段抬高型心肌梗死的溶栓療效比較[J].中國(guó)心血管病研究,2011,09(3):181-183.
[15]金焱,劉東亮.瑞替普酶治療急性心肌梗死100例臨床療效分析[J].中國(guó)實(shí)用醫(yī)刊,2014,(11):47-48.
[16]金焱,崔四龍,劉東亮,金鵬,胡新榮,李凌,林靜.交感風(fēng)暴9例臨床分析[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2013,16(1):55-56.
[17]彭庚,劉東亮,董艷彩,華潞,劉玉清.抗心律失常藥物不良反應(yīng)分析[J].中國(guó)實(shí)用醫(yī)藥,2015,(4):17-19.
[18]董艷彩,劉東亮.冠狀動(dòng)脈慢血流現(xiàn)象相關(guān)因素分析及治療體會(huì)[J].中華實(shí)用診斷與治療雜志,2008,22(11):870-871.
[19]金焱,崔四龍,金鵬,劉東亮,陸振濤,李凌.芪藶強(qiáng)心膠囊治療缺血性心肌病心力衰竭50例療效觀察[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2012,15(10):1490-1492.
[20]錢春麗,劉東亮,劉燕,栗浩.老年冠心病無(wú)癥狀心肌缺血臨床分析[J].實(shí)用診斷與治療雜志,2008,22(4):307-308.
[21]金焱,劉東亮.血N端B型鈉尿肽原對(duì)心力衰竭診斷價(jià)值及與心功能分級(jí)關(guān)系的探討[J].中華實(shí)用診斷與治療雜志,2009,23(9):850-851,854.
[22]張彥周,劉東亮,閆西艴.心肌梗死后心室重塑的防治[J].心血管病學(xué)進(jìn)展,2000,21(4):217-220.
[23]金焱,崔四龍,劉東亮,金鵬,胡新榮,李凌,林靜.瑞替普酶與阿替普酶在急性肺栓塞溶栓治療中的比較研究[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2012,15(11):1668-1670.
[24]劉東亮.介入治療對(duì)冠心病患者血漿腦鈉素水平及心室重塑的影響[J].中國(guó)心血管病研究雜志,2006,4(9):675-677.
[25]粟浩,劉東亮,錢春麗.動(dòng)態(tài)心電圖診斷病毒性心肌炎應(yīng)用價(jià)值[J].中華實(shí)用診斷與治療雜志,2009,23(3):268-269.
[26]劉東亮,宋國(guó)華,金焱,崔四龍,金鵬,胡新榮,李凌,林靜.瑞替普酶與阿替普酶在急性肺栓塞溶栓治療中的療效對(duì)比研究[J].實(shí)用心腦肺血管病雜志,2012,20(12):1962-1963.
[27]呂云霞,劉東亮,鄭明空,蔡繼銳,楊春香.我院CCU急性冠脈綜合征患者心理狀況調(diào)查[J].中國(guó)誤診學(xué)雜志,2012,12(10):2383.
[28]伊?xí)t,劉東亮.中西醫(yī)結(jié)合治療肺心病心力衰竭58例療效觀察[J].中國(guó)誤診學(xué)雜志,2004,4(8):1250-1250.
[29]胡新榮,劉東亮,陳素珍,呂云霞.風(fēng)濕性心臟病心房纖顫患者華法林抗凝治療的臨床觀察[J].中國(guó)基層醫(yī)藥,2007,14(1):53-54.
[30]王前勝,劉東亮,董艷彩,晉學(xué)慶,盧卓強(qiáng).ACE2基因表達(dá)增加對(duì)人臍靜脈內(nèi)皮細(xì)胞增殖、凋亡的影響[J].中國(guó)心血管病研究,2013,11(7):540-544,后插4-后插5.
[31]張建華,張素貞,劉東亮,董敬遠(yuǎn),陶志敏.低分子肝素與普通肝素用于冠脈內(nèi)支架置入術(shù)患者療效比較[J].中國(guó)藥師,2006,9(2):108-110.
[32]劉東亮,董艷彩,萬(wàn)霞,劉素紅,胡雯,李葉寧.阻塞性睡眠呼吸暫停低通氣綜合征與臨床高血壓的關(guān)系[J].實(shí)用診斷與治療雜志,2005,19(2):137-138.
[33]蔡繼銳,劉東亮,楊春香,楊自瑩.冠心病病變程度與竇性心率震蕩關(guān)系的研究[J].中國(guó)心血管病研究,2009,7(4):256-258.
[34]胡新榮,侯新鳳,劉東亮.甲狀腺機(jī)能亢進(jìn)性心臟病誤診16例分析[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2007,10(11):1332-1333.
[35]蔡繼銳,劉東亮,毛艷,馬俊英,呂云霞.埋藏式心臟起搏器268例臨床分析[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2013,16(12):1951-1953.
[36]金焱,崔四龍,劉東亮,李凌,軒艷婷,林靜.芪藶強(qiáng)心膠囊治療圍生期心肌病30例臨床分析[J].中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志,2013,16(5):722-724.
[37]劉東亮,金焱,崔四龍,金鵬,王前勝,李凌,胡艷輝.芪藶強(qiáng)心膠囊治療圍生期心肌病療效觀察[J].中國(guó)誤診學(xué)雜志,2012,12(18):4988-4989.
[38]金鵬,李琳,劉東亮.硝普鈉對(duì)冠心病心力衰竭患者血漿腦鈉肽濃度的影響[J].中華實(shí)用診斷與治療雜志,2009,23(3):308-309.
[39]劉東亮.依那普利與倍他樂(lè)克聯(lián)用治療左室舒張性心力衰竭初步臨床研究[J].醫(yī)學(xué)研究雜志,2006,35(9):45-46.
[40]劉東亮.卡維地洛對(duì)擴(kuò)張型心肌病患者QT間期離散度的影響[C].中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)第十次全國(guó)心血管病學(xué)術(shù)會(huì)議匯編.2008:.
[41]董艷彩,劉東亮.卡維地洛對(duì)擴(kuò)張型心肌病患者靜息心電圖QT間期離散度的影響[J].中國(guó)社區(qū)醫(yī)師（醫(yī)學(xué)專業(yè)半月刊）,2009,11(13):20-21.
[42]蔡繼銳,毛艷,劉東亮,胡新榮,董艷彩.永久起搏器右室不同部位起搏臨床觀察[J].中國(guó)實(shí)用醫(yī)藥,2016,11(27):51-53.
[43]許根友,李慶紅,劉東亮.心臟舒縮功能不全并反復(fù)發(fā)生室性心律失常68例臨床分析[J].中國(guó)綜合臨床,2003,19(8):694-695.
[44]蔡繼銳,劉仁光,劉東亮.粒細(xì)胞集落刺激因子與干細(xì)胞因子合用對(duì)急性心肌梗死模型大鼠心功能的影響[J].中國(guó)組織工程研究與臨床康復(fù),2007,11(7):1394-1396.
[45]楊秀慧,劉東亮,李慶紅,李燕輝.臥位型心絞痛21例分析[J].中國(guó)誤診學(xué)雜志,2002,2(8):1244-1245.
[46]李葉寧,郭雅琴,劉東亮,胡新榮.急性肺血栓栓塞癥26例臨床分析[J].現(xiàn)代醫(yī)藥衛(wèi)生,2004,20(3):180-180.
[47]彭庚,謝文燕,劉東亮,董艷彩.120例胺碘酮不良反應(yīng)分析[J].中國(guó)實(shí)用醫(yī)藥,2015,(19):10-11,12.
[48]劉東亮,吳玲,張彥周,閻西艴.缺血及再灌注性室顫心臟去甲腎上腺素的釋放[J].中國(guó)誤診學(xué)雜志,2001,1(5):689-690.
[49]金焱,崔四龍,劉東亮.血管內(nèi)超聲在左主干病變的臨床應(yīng)用觀察[J].中國(guó)實(shí)用醫(yī)藥,2013,(33):75-76.
[50]劉東亮,蔡繼銳,金鵬,楊春香.G-CSF治療大鼠急性心肌梗死的實(shí)驗(yàn)研究[J].中國(guó)誤診學(xué)雜志,2007,7(8):1676-1678.
[1]Wang H, Bai J, He B, Hu X, Liu D. Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies. Scientific Reports 2016, 6: 39672.
[2]Wang H, Peng G, Bai J, He B, Huang K, Hu X, Liu D. Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta-Analysis of Prospective Studies Up to 2016. Journal of the American Heart Association 2017, 6(7).
[3]Wang H, Liu L, Zhao J, Cui G, Chen C, Ding H, Wang DW. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One 2013, 8(6): e67665.
[4]Wang H, Miao K, Zhao J, Liu L, Cui G, Chen C, Wang DW, Ding H. Common variants in KCNQ1 confer increased risk of type 2 diabetes and contribute to the diabetic epidemic in East Asians: a replication and meta-analysis. Ann Hum Genet 2013, 77(5): 380-391.
[5]Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, Hui R, Ding H, Wang DW. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. Journal of neuroinflammation 2012, 9: 235.
[6]Dong L, Wang H, Wang DW, Ding H. Association of chromosome 9p21 genetic variants with risk of coronary heart disease in the East Asian population: a meta-analysis. Ann Hum Genet 2013, 77(3): 183-190.
[7]Cui G, Li Z, Li R, Huang J, Wang H, Zhang L, Ding H, Wang DW. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. Journal of the American College of Cardiology 2014, 64(3): 267-277.
[8]Xu Y, Gong W, Peng J, Wang H, Huang J, Ding H, Wang DW. Functional analysis LRP6 novel mutations in patients with coronary artery disease. PLoS One 2014, 9(1): e84345.
[9]Zhao J, Miao K, Wang H, Ding H, Wang DW. Association between telomere length and type 2 diabetes mellitus: a meta-analysis. PLoS One 2013, 8(11): e79993.
[10]Bai J, Ding X, Du X, Zhao X, Wang Z, Ma Z. Diabetes is associated with increased risk of venous thromboembolism: A systematic review and meta-analysis. Thrombosis Research 2015, 135(1): 90-95.
[11]Li Y, Bai J, He B, Wang N, Wang H, Liu D. Weak association between the interleukin-8 rs4073 polymorphism and acute pancreatitis: a cumulative meta-analysis. BMC Med Genet 2019, 20(1): 129.
[12]Li Y, Zhou P, Cui W, Li C, Xiao W, Wen Y, Wang H, Wang H. Immediate anterior open reduction and plate fixation in the management of lower cervical dislocation with facet interlocking. Sci Rep 2019, 9(1): 1286.
[13]Wang H, Peng G, Dong Y, Liu D. Intravascular ultrasound findings and stent implantation for a patient with coronary spastic angina at site of progressive atherosclerotic plaque and responded poorly to medical treatment: a case report. BMC Cardiovasc Disord 2019, 19(1): 300.
